Twin Tree Management
MRNA icon

Twin Tree Management’s Moderna MRNA Stock Holding History

Twin Tree Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-63,700
Closed -$1.65M – 1616
2025
Q3 		$1.65M Sell
63,700
-251,200
-80% -$7.01M 0.01% 1090
2025
Q2 		$8.69M Sell
314,900
-1,078,500
-77% -$28.4M 0.02% 821
2025
Q1 		$39.5M Buy
1,393,400
+1,188,300
+579% +$42.2M 0.07% 232
2024
Q4 		$8.53M Sell
205,100
-85,400
-29% -$4.08M 0.02% 753
2024
Q3 		$19.4M Sell
290,500
-409,200
-58% -$37.6M 0.04% 426
2024
Q2 		$83.1M Buy
699,700
+458,000
+189% +$58M 0.19% 96
2024
Q1 		$25.8M Sell
241,700
-271,000
-53% -$27.3M 0.06% 344
2023
Q4 		$51M Sell
512,700
-87,300
-15% -$7.34M 0.1% 198
2023
Q3 		$62M Sell
600,000
-95,700
-14% -$10.7M 0.14% 143
2023
Q2 		$84.5M Buy
695,700
+307,600
+79% +$41M 0.13% 125
2023
Q1 		$59.6M Sell
388,100
-711,400
-65% -$117M 0.11% 155
2022
Q4 		$197M Buy
1,099,500
+230,500
+27% +$37.7M 0.43% 28
2022
Q3 		$103M Buy
869,000
+171,000
+24% +$25.9M 0.2% 72
2022
Q2 		$99.7M Buy
698,000
+151,000
+28% +$21.6M 0.16% 72
2022
Q1 		$94.2M Buy
547,000
+22,900
+4% +$3.86M 0.15% 101
2021
Q4 		$133M Sell
524,100
-284,300
-35% -$83.1M 0.28% 40
2021
Q3 		$311M Buy
808,400
+280,600
+53% +$103M 0.69% 9
2021
Q2 		$124M Buy
527,800
+273,600
+108% +$48.9M 0.33% 44
2021
Q1 		$33.3M Buy
+254,200
New +$36.8M 0.12% 171
2020
Q4 		– Sell
-265,800
Closed -$18.8M – 1415
2020
Q3 		$18.8M Sell
265,800
-200,700
-43% -$14M 0.08% 280
2020
Q2 		$30M Buy
466,500
+3,900
+0.8% +$214K 0.12% 189
2020
Q1 		$13.9M Buy
+462,600
New +$10.6M 0.07% 257

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Twin Tree Management's MRNA Position: Q1 2026 in Review

Twin Tree Management increased its Moderna (MRNA) stake by 84% in Q1 2026, buying an estimated $2.66M and bringing the position to 125,203 shares worth $6.36M. The position accounts for 0.13% of the portfolio, ranked #166.

Twin Tree Management first reported a position in MRNA in Q1 2020 and has held it in 20 quarters since. The position peaked at $47.5M in Q4 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Twin Tree Management held 125,203 shares of Moderna worth $6.36M as of Q1 2026.
  • Twin Tree Management bought 57,026 Moderna shares in Q1 2026, an estimated $2.66M.
  • Moderna made up 0.13% of Twin Tree Management's portfolio in Q1 2026, its #166 holding.
  • Twin Tree Management first reported a position in Moderna in Q1 2020 and has held it in 20 quarters since.
  • Twin Tree Management's Moderna position peaked at $47.5M in Q4 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Twin Tree Management's 13F filing for Q1 2026, filed 14 May 2026.